Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Twist Bioscience to Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on Wednesday, December 11, 2019


Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fourth quarter and fiscal year ended September 30, 2019, following the close of market on Wednesday, December 11, 2019. The company plans to hold a conference call and live audio webcast for analysts and investors at 4:30 p.m. Eastern Time to discuss its financial results and provide an update on the company's business. The press release with the financial results will be accessible from the company's website prior to the conference call through the Investor Relations section under the "Company" tab at www.twistbioscience.com.

The call can be accessed by dialing (866) 688-0947 (domestic) or (409) 217-8781 (international) and refer to the conference ID 2136036. A telephonic replay of the conference call will be available beginning approximately four hours after the call through December 18, 2019 and may be accessed by dialing (855) 859-2056 (domestic) or (404) 537-3406 (international). The replay conference ID is 2136036. The webcast replay will be available for two weeks.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by "writing" DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube


These press releases may also interest you

at 07:00
The Centrale des syndicats du Québec (CSQ) and its affiliated federations ? the Fédération des syndicats de l'enseignement , the Fédération du personnel de soutien scolaire (FPSS-CSQ), the Fédération des professionnelles et professionnels de...

at 01:00
SYSTRAN, the leader in neural automated translation technology, announces that EJADA, one of the leading digital services companies in the Middle East, has chosen its AI-based Natural Language Processing solutions to address, in a first stage, Saudi...

23 jan 2021
Guardian Energy Management Solutionstm, a Massachusetts based energy services provider, has been acquired by energy and software industry executive Domenic Armano, P.E. Mr. Armano, a seasoned executive with over two decades of sales, customer...

23 jan 2021
Pilots represented by Unifor Local 7378 have reached a tentative agreement with Sunwing Airlines. "I applaud the leadership of Unifor 7378 for their grit and determination in fighting for a collective agreement that benefits our members during these...

23 jan 2021
The U.S. Small Business Administration (SBA) announced that Raptamer Discovery Group is one of only 38 companies, seven organizations and 14 individuals in the country to receive the prestigious Tibbetts Award for their accomplishments in creating...

23 jan 2021
On December 21, 2020, Congress passed a bipartisan $900 billion COVID-19 relief bill, known as the Consolidated Appropriations Act (CAA), which was signed into law on December 27, 2020. The pandemic relief includes $25 billion directly to States,...



News published on 20 november 2019 at 08:05 and distributed by: